Fleseriu, M.
~ 100  Ergebnisse:
Personensuche X
?
2

CLINICAL IMPROVEMENTS IN INDIVIDUALS WITH CUSHING'S DISEASE..:

Lacroix, A. ; Newell-Price, J. ; Fleseriu, M....
Canadian Journal of Cardiology.  39 (2023)  10 - p. S159-S160 , 2023
 
?
5

OSILODROSTAT DOSING CONSIDERATIONS IN CUSHING'S DISEASE: A ..:

Fleseriu, M. ; Pivonello, R. ; Lacroix, A....
Canadian Journal of Cardiology.  39 (2023)  10 - p. S164 , 2023
 
?
6

Contributors:

, In: Endocrine Hypertension,
 
?
8

Predictive factors for decreased baseline quality of life i..:

Fleseriu, Cara M. ; Beswick, Daniel M. ; Maoz, Sabrina L....
International Forum of Allergy & Rhinology.  14 (2023)  4 - p. 775-785 , 2023
 
?
10

OSILODROSTAT DOSING CONSIDERATIONS IN CUSHING'S DISEASE: A ..:

Fleseriu, M. ; Pivonello, R. ; Lacroix, A....
Canadian Journal of Diabetes.  47 (2023)  7 - p. S133-S134 , 2023
 
?
 
?
12

THU032 Osilodrostat Is Effective And Well Tolerated In Pati..:

Snyder, Peter J ; Biller, Beverly M K ; Fleseriu, Maria...
Journal of the Endocrine Society.  7 (2023)  Supplement_1 - p. , 2023
 
?
13

CLINICAL IMPROVEMENTS IN INDIVIDUALS WITH CUSHING'S DISEASE..:

Lacroix, A. ; Newell-Price, J. ; Fleseriu, M....
Canadian Journal of Diabetes.  47 (2023)  7 - p. S129-S130 , 2023
 
?
14

Long‐term quality of life after treatment in sinonasal mali..:

Maoz, Sabrina L. ; Wang, Eric W. ; Hwang, Peter H....
International Forum of Allergy & Rhinology.  13 (2023)  11 - p. 2030-2042 , 2023
 
?
 
1-15